Denali Therapeutics secures $275 million royalty deal with Royalty Pharma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/13/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Denali Therapeutics secures $275 million royalty deal with Royalty Pharma
(NASDAQ: DNLI) Delayed: 21.09 -0.31 (1.45%)
Previous Close $21.40    52 Week High $ 
Open $21.65    52 Week Low $ 
Day High $21.79    P/E N/A 
Day Low $21.06    EPS $ 
Volume 1,239,511       

REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 58.61 -0.14 (0.24%)
Previous Close $58.75    52 Week High $3.48 
Open $58.95    52 Week Low $0.80 
Day High $59.54    P/E N/A 
Day Low $58.35    EPS $-1.54 
Volume 2,596,068